The findings, which were presented over the weekend at ENDO 2026, the Endocrine Society's annual meeting, were based on an analysis of health records from more than 42,000 adults who were already taking at least two types of blood pressure medications when they began treatment with GLP-1 drugs such as semaglutide, tirzepatide or liraglutide
13 min read Comparison Semaglutide vs Retatrutide: Single vs Triple Agonist Weight Loss 8 min read Comparison Tirzepatide vs Retatrutide: Dual vs Triple GIP/GLP-1/Glucagon Agonists 8 min read Comparison Retatrutide vs AOD-9604: Next-Gen vs Legacy Weight Loss 5 min read Comparison Survodutide vs Tirzepatide vs Retatrutide: Next-Gen Weight Loss Drugs Compared 9 min read Comparison About this article: Written by the PeptideMark Research Team and reviewed by Richard Hayes, Editor-in-Chief
Novo launched on January 5th
Episode 18: Boost GLP-1 Tolerance and Weight-Loss Success with L-Carnitine, Vitamin B6, and Vitamin B12 Discover a simple yet powerful strategy to help you stick with your GLP-1 weight-loss journey
Obesity has been observed to arise from a combination of social, genetic, metabolic, and psychological variables, with recent poor health behavior trends (diet and sedentary lifestyles) exacerbating the epidemic
Comprehensive Catalog: Your research shouldn't be limited